Valuation : Labcorp Holdings Inc.

Market Cap 26.98B 23.27B 21.89B 19.94B 37.5B 2,560B 37.71B 259B 101B 1,302B 101B 99.1B 4,319B P/E 2026 *
23.9x
P/E 2027 * 21.4x
Enterprise Value 32.09B 27.68B 26.04B 23.72B 44.61B 3,046B 44.85B 308B 120B 1,549B 120B 118B 5,137B EV / Sales 2026 *
2.18x
EV / Sales 2027 * 2.03x
Free-Float
99.65%
Yield 2026 *
0.88%
Yield 2027 * 0.89%
1 day-0.79%
1 week-2.27%
Current month-0.80%
1 month+7.35%
3 months+28.47%
6 months+15.20%
Current year+31.54%
1 week 329.28
Extreme 329.28
341.8
1 month 300.58
Extreme 300.58
341.8
Current year 245
Extreme 245
341.8
1 year 244.52
Extreme 244.52
341.8
3 years 191.97
Extreme 191.97
341.8
5 years 191.97
Extreme 191.97
341.8
10 years 98.02
Extreme 98.02
341.8
Date Insider Type Main position Quantity % Market Cap. Importance
17/08/26 Sell

Director

-3,000 0.0037%
11/08/26 Sell

Chief Executive Officer

-4,669 0.0057%
04/08/26 Sell

Responsable ventes & marketing

-924 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%-2.27%+20.54%+59.75% 26.98B
+0.35%-4.71%+89.48%+413.21% 46.41B
+0.26%-8.40%-18.34%-38.93% 6.93B
+0.30%-1.76%+7.40%+131.84% 5.97B
-1.56%+1.09%+15.11%+75.04% 3.4B
-0.55%-3.79%-34.40%+1,770.75% 2.53B
-1.40%+4.71%+99.55%+15.89% 2.3B
+4.23%+4.45%+26.68%+32.18% 2.07B
-0.22%-8.11%-14.49%-54.21% 1.89B
-0.54%-7.37%+1.16%-19.54% 1.68B
Average +0.01%-0.14%+19.27%+238.60% 10.01B
Weighted average by Cap. -0.04%-1.19%+48.40%+259.69%

Financials

2026 *2027 *
Net sales 14.75B 12.72B 11.97B 10.9B 20.5B 1,400B 20.61B 141B 55.07B 712B 55.38B 54.18B 2,361B 15.47B 13.35B 12.56B 11.44B 21.51B 1,469B 21.63B 148B 57.77B 747B 58.1B 56.84B 2,477B
Net income 1.13B 975M 917M 836M 1.57B 107B 1.58B 10.84B 4.22B 54.57B 4.24B 4.15B 181B 1.24B 1.07B 1.01B 918M 1.73B 118B 1.74B 11.91B 4.64B 59.97B 4.66B 4.56B 199B
Net Debt 5.11B 4.41B 4.15B 3.78B 7.11B 485B 7.15B 49.04B 19.09B 247B 19.2B 18.78B 818B 4.41B 3.8B 3.58B 3.26B 6.13B 418B 6.16B 42.27B 16.45B 213B 16.54B 16.19B 705B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
01/09/26 US$330.21 -0.74% 195,174
31/08/26 US$332.66 -0.73% 851,157
28/08/26 US$335.11 -0.42% 456,546
27/08/26 US$336.54 +0.24% 673,625
26/08/26 US$335.72 -0.58% 701,207
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
332.66USD
Average target price
341.50USD
Spread / Average Target
+2.66%

Quarterly revenue - Rate of surprise